Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Bedognetti

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Cancer Cell|September 15, 2020
A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic MalignanciesDavide Bedognetti
Oncoimmunology|October 24, 2014
Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcomeDavide Bedognetti, Ena Wang, Francesco M Marincola
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Functional Genome Profiling to Understand Cancer Immune ResponsivenessEna Wang, Davide Bedognetti, Francesco M Marincola
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Prediction of response to anticancer immunotherapy using gene signaturesEna Wang, Davide Bedognetti, Francesco M Marincola
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 4, 2010
Gynaecomastia: the anastrozole paradoxDavide Bedognetti, Alessandra Rubagotti, Gabriele Zoppoli, et al.
Annals of the New York Academy of Sciences|May 9, 2013
Common pathways to tumor rejectionEna Wang, Davide Bedognetti, Sara Tomei, et al.
Cancer Treatment and Research|March 28, 2020
The Biology of Immune-Active Cancers and Their Regulatory MechanismsDavide Bedognetti, Alessandra Cesano, Francesco M Marincola, et al.
Expert Review of Vaccines|June 4, 2010
Gene-expression profiling in vaccine therapy and immunotherapy for cancerDavide Bedognetti, Ena Wang, Mario Roberto Sertoli, et al.
Immunity|July 30, 2013
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signaturesJérôme Galon, Helen K Angell, Davide Bedognetti, et al.
Emerging Topics in Life Sciences|February 2, 2021
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapyDavide Bedognetti, Jessica Roelands, Julie Decock, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Cancer Cell|September 15, 2020
A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic MalignanciesDavide Bedognetti
Oncoimmunology|October 24, 2014
Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcomeDavide Bedognetti, Ena Wang, Francesco M Marincola
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Functional Genome Profiling to Understand Cancer Immune ResponsivenessEna Wang, Davide Bedognetti, Francesco M Marincola
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Prediction of response to anticancer immunotherapy using gene signaturesEna Wang, Davide Bedognetti, Francesco M Marincola
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 4, 2010
Gynaecomastia: the anastrozole paradoxDavide Bedognetti, Alessandra Rubagotti, Gabriele Zoppoli, et al.
Annals of the New York Academy of Sciences|May 9, 2013
Common pathways to tumor rejectionEna Wang, Davide Bedognetti, Sara Tomei, et al.
Cancer Treatment and Research|March 28, 2020
The Biology of Immune-Active Cancers and Their Regulatory MechanismsDavide Bedognetti, Alessandra Cesano, Francesco M Marincola, et al.
Expert Review of Vaccines|June 4, 2010
Gene-expression profiling in vaccine therapy and immunotherapy for cancerDavide Bedognetti, Ena Wang, Mario Roberto Sertoli, et al.
Immunity|July 30, 2013
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signaturesJérôme Galon, Helen K Angell, Davide Bedognetti, et al.
Emerging Topics in Life Sciences|February 2, 2021
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapyDavide Bedognetti, Jessica Roelands, Julie Decock, et al.
Pageof 15